Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-19 Purchase |
2022-01-21 7:22 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
158,417 | $9.9656 | $1,578,717 | 17,041,802 (Indirect) |
View |
| 2022-01-19 Purchase |
2022-01-21 7:18 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
158,417 | $9.9656 | $1,578,717 | 17,041,802 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 7:27 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
44,717 | $9.9012 | $442,750 | 16,883,385 (Indirect) |
View |
| 2022-01-11 Purchase |
2022-01-13 7:18 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
44,717 | $9.9012 | $442,750 | 16,883,385 (Indirect) |
View |
| 2021-12-21 Purchase |
2021-12-22 6:26 pm |
Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO |
2,600 | $9.7621 | $25,381 | 348,530 (Direct) |
View |
| 2021-12-21 Purchase |
2021-12-22 6:21 pm |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
1,970 | $10.15 | $20,000 | 1,970 (Direct) |
View |
| 2021-10-12 Purchase |
2021-10-14 5:00 pm |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
625,000 | $16 | $10,000,000 | 499,150 (Indirect) |
View |
| 2021-10-12 Purchase |
2021-10-14 5:00 pm |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
625 | $16 | $10,000 | 388,949 (Direct) |
View |
| 2021-10-12 Purchase |
2021-10-14 5:00 pm |
Theseus Pharmaceuticals Inc. | THRX | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
250,000 | $16 | $4,000,000 | 599,320 (Indirect) |
View |
| 2021-10-12 Purchase |
2021-10-14 5:00 pm |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
625,000 | $16 | $10,000,000 | 499,150 (Indirect) |
View |
| 2021-10-12 Purchase |
2021-10-14 4:40 pm |
Theseus Pharmaceuticals Inc. | THRX | Omega Fund VI L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari Former 10% owner |
187,500 | $16 | $3,000,000 | 711,479 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Kerstein David Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO |
450,000 | $0 | 450,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Dalgarno David Chief Technical Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
180,000 | $0 | 180,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-23 8:00 pm |
N/A 2032-02-17 |
Theseus Pharmaceuticals Inc. | THRX | Rivera Victor Chief Scientific Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-10-12 Conversion |
2021-10-15 6:40 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | TAKEDA PHARMACEUTICAL CO LTD ARIAD PHARMACEUTICALS INC 10% Owner |
1,615,427 | $0 | 1,615,427 (Indirect) |
View |
Ownership |
2021-10-15 6:10 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | TAKEDA PHARMACEUTICAL CO LTD ARIAD PHARMACEUTICALS INC 10% Owner |
0 | $0 | 1,615,427 (Indirect) |
View |
| 2021-10-12 Conversion |
2021-10-14 5:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
31,990,686 | $0 | 499,150 (Indirect) |
View |
| 2021-10-12 Conversion |
2021-10-14 5:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
436,649 | $0 | 599,320 (Indirect) |
View |
| 2021-10-12 Conversion |
2021-10-14 5:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
31,990,686 | $0 | 499,150 (Indirect) |
View |
| 2021-10-12 Conversion |
2021-10-14 4:40 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Omega Fund VI L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari Former 10% owner |
1,217,131 | $0 | 711,479 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 7:00 pm |
N/A 2031-10-05 |
Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Chairman |
22,678 | $0 | 22,678 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 7:00 pm |
N/A 2031-10-05 |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
22,678 | $0 | 22,678 (Direct) |
View |
| 2021-10-06 Option Award |
2021-10-08 7:00 pm |
N/A 2031-10-05 |
Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director |
22,678 | $0 | 22,678 (Direct) |
View |
Ownership |
2021-10-06 7:49 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner |
0 | $0 | 523,979 (Direct) |
View |
Ownership |
2021-10-06 7:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
0 | $0 | 436,649 (Indirect) |
View |
Ownership |
2021-10-06 7:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Rivera Victor Chief Scientific Officer |
0 | $0 | 830,283 (Direct) |
View |
Ownership |
2021-10-06 7:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Shakespeare William See Remarks |
0 | $0 | 996,341 (Direct) |
View |
Ownership |
2021-10-06 7:01 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dukes Iain D. Chairman |
0 | $0 | 830,283 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A 2030-12-23 |
Theseus Pharmaceuticals Inc. | THRX | Kerstein David Chief Medical Officer |
0 | $0 | 380,456 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A 2031-06-04 |
Theseus Pharmaceuticals Inc. | THRX | Yi Kathy Director |
0 | $0 | 99,634 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A 2031-05-26 |
Theseus Pharmaceuticals Inc. | THRX | Dahms Bradford D. Chief Financial Officer |
0 | $0 | 355,999 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | Dalgarno David Chief Technical Officer |
0 | $0 | 830,283 (Direct) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | GORDON CARL L Director 10% Owner |
0 | $0 | 16,213,668 (Indirect) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner |
0 | $0 | 16,213,668 (Indirect) |
View |
Ownership |
2021-10-06 7:00 pm |
N/A N/A |
Theseus Pharmaceuticals Inc. | THRX | CLACKSON TIMOTHY P President and CEO |
0 | $0 | 1,494,513 (Direct) |
View |